Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials.

Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Fujimoto G, Azuma K, Shirakawa M, Hanson ME, Fujita KP.

Hypertens Res. 2014 Dec;37(12):1088. doi: 10.1038/hr.2014.147. No abstract available.

PMID:
25475417
[PubMed - in process]
2.

Evaluation of blood pressure reduction response and responder characteristics to fixed-dose combination treatment of amlodipine and losartan: a post hoc analysis of pooled clinical trials.

Unniachan S, Wu D, Rajagopalan S, Hanson ME, Fujita KP.

J Clin Hypertens (Greenwich). 2014 Sep;16(9):671-7. doi: 10.1111/jch.12390. Epub 2014 Aug 7.

PMID:
25098858
[PubMed - in process]
3.

Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials.

Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Fujimoto G, Azuma K, Shirakawa M, Hanson ME, Fujita KP.

Hypertens Res. 2014 Dec;37(12):1042-9. doi: 10.1038/hr.2014.114. Epub 2014 Jul 3.

PMID:
24990091
[PubMed - in process]
4.

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years.

Constance C, Ben-Yehuda O, Wenger NK, Zieve F, Lin J, Hanson ME, Lowe RS, Tershakovec AM.

Lipids Health Dis. 2014 Jan 13;13:13. doi: 10.1186/1476-511X-13-13.

PMID:
24411003
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects.

Rosen JB, Jimenez JG, Pirags V, Vides H, Massaad R, Hanson ME, Brudi P, Triscari J.

Lipids Health Dis. 2013 Jul 16;12:103. doi: 10.1186/1476-511X-12-103.

PMID:
23866306
[PubMed - in process]
Free PMC Article
6.

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.

Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS.

Vasc Health Risk Manag. 2013;9:273-82. doi: 10.2147/VHRM.S44330. Epub 2013 May 29. Review.

PMID:
23761972
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.

Rosen JB, Jimenez JG, Pirags V, Vides H, Hanson ME, Massaad R, McPeters G, Brudi P, Triscari J.

Diab Vasc Dis Res. 2013 May;10(3):277-86. doi: 10.1177/1479164112465212. Epub 2013 Jan 3.

PMID:
23288881
[PubMed - indexed for MEDLINE]
Free Article
8.

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.

Jimenez JG, Rosen JB, Pirags V, Massaad R, Hanson ME, Brudi P, Triscari J.

Diabetes Obes Metab. 2013 Jun;15(6):513-22. doi: 10.1111/dom.12059. Epub 2013 Jan 25.

PMID:
23279632
[PubMed - indexed for MEDLINE]
9.

Intronic parent-of-origin dependent differential methylation at the Actn1 gene is conserved in rodents but is not associated with imprinted expression.

Calaway JD, Domínguez JI, Hanson ME, Cambranis EC, Pardo-Manuel de Villena F, de la Casa-Esperon E.

PLoS One. 2012;7(11):e48936. doi: 10.1371/journal.pone.0048936. Epub 2012 Nov 8.

PMID:
23145029
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks.

Toth PP, Morrone D, Weintraub WS, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM.

Int J Clin Pract. 2012 Aug;66(8):800-812. doi: 10.1111/j.1742-1241.2012.02964.x.

PMID:
22805272
[PubMed - as supplied by publisher]
12.

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial.

Yu CC, Lai WT, Shih KC, Lin TH, Lu CH, Lai HJ, Hanson ME, Hwang JJ.

BMC Res Notes. 2012 May 23;5:251. doi: 10.1186/1756-0500-5-251.

PMID:
22621316
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Characterizing the compression-dependent viscoelastic properties of human hepatic pathologies using dynamic compression testing.

DeWall RJ, Bharat S, Varghese T, Hanson ME, Agni RM, Kliewer MA.

Phys Med Biol. 2012 Apr 21;57(8):2273-86. doi: 10.1088/0031-9155/57/8/2273. Epub 2012 Mar 30.

PMID:
22459948
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.

Morrone D, Weintraub WS, Toth PP, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM.

Atherosclerosis. 2012 Aug;223(2):251-61. doi: 10.1016/j.atherosclerosis.2012.02.016. Epub 2012 Feb 16. Review.

PMID:
22410123
[PubMed - indexed for MEDLINE]
15.

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.

Hing Ling PK, Civeira F, Dan AG, Hanson ME, Massaad R, De Tilleghem Cle B, Milardo C, Triscari J.

Lipids Health Dis. 2012 Jan 31;11:18. doi: 10.1186/1476-511X-11-18.

PMID:
22293030
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MRI of pregnancy-related issues: müllerian duct anomalies.

Robbins JB, Parry JP, Guite KM, Hanson ME, Chow LC, Kliewer MA, Sadowski EA.

AJR Am J Roentgenol. 2012 Feb;198(2):302-10. doi: 10.2214/AJR.11.7789. Review.

PMID:
22268172
[PubMed - indexed for MEDLINE]
17.

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).

Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM.

J Clin Lipidol. 2011 Nov-Dec;5(6):474-82. doi: 10.1016/j.jacl.2011.06.004. Epub 2011 Jun 15.

PMID:
22108151
[PubMed - indexed for MEDLINE]
18.

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.

Insinga RP, Ng-Mak DS, Hanson ME.

Cephalalgia. 2011 Nov;31(15):1570-5. doi: 10.1177/0333102411425960. Epub 2011 Oct 19.

PMID:
22013140
[PubMed - indexed for MEDLINE]
19.

Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.

Abramson BL, Benlian P, Hanson ME, Lin J, Shah A, Tershakovec AM.

Lipids Health Dis. 2011 Aug 22;10:146. doi: 10.1186/1476-511X-10-146.

PMID:
21859459
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years.

Ben-Yehuda O, Wenger NK, Constance C, Zieve F, Hanson ME, Lin JX, Shah AK, Jones-Burton C, Tershakovec AM.

J Geriatr Cardiol. 2011 Mar;8(1):1-11. doi: 10.3724/SP.J.1263.2011.00001.

PMID:
22783278
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk